Novel Chromosome 5 Inversion Associated With PDGFRB Rearrangement in Hypereosinophilic Syndrome.
作者信息
Saultz Jennifer N, Kaffenberger Ben H, Taylor Montoya, Heerema Nyla A, Klisovic Rebecca
机构信息
Division of Medical Oncology, Department of Internal Medicine, The Ohio State University, Columbus2Division of Hematology, Department of Internal Medicine, The Ohio State University, Columbus.
Division of Dermatology, Department of Internal Medicine, The Ohio State University, Columbus.
出版信息
JAMA Dermatol. 2016 Dec 1;152(12):1391-1393. doi: 10.1001/jamadermatol.2016.3175.
Abstract
摘要
相似文献
1
Novel Chromosome 5 Inversion Associated With PDGFRB Rearrangement in Hypereosinophilic Syndrome.
JAMA Dermatol. 2016 Dec 1;152(12):1391-1393. doi: 10.1001/jamadermatol.2016.3175.
2
A Novel PCM1-PDGFRB Fusion in a Patient with a Chronic Myeloproliferative Neoplasm and an ins(8;5).
Acta Haematol. 2017;138(4):198-200. doi: 10.1159/000484077. Epub 2017 Nov 24.
3
Imatinib mesylate for unmutated hypereosinophilic syndromes: Does it work?
Eur J Intern Med. 2016 Jul;32:e19-20. doi: 10.1016/j.ejim.2016.02.024. Epub 2016 Mar 8.
4
A novel fusion of PDGFRB to TSC1, an intrinsic suppressor of mTOR-signaling pathway, in a chronic eosinophilic leukemia patient with t(5;9)(q32;q34).
Leuk Lymphoma. 2018 Oct;59(10):2506-2508. doi: 10.1080/10428194.2018.1427855. Epub 2018 Jan 31.
5
Effective treatment of hypereosinophilic syndrome with imatinib mesylate.
Hematol J. 2003;4(6):410-2. doi: 10.1038/sj.thj.6200294.
6
Imatinib mesylate as a novel treatment option for hypereosinophilic syndrome: two case reports and a comprehensive review of the literature.
Ann Hematol. 2006 Jan;85(1):1-16. doi: 10.1007/s00277-005-1084-7. Epub 2005 Sep 1.
7
Eosinophilia in Hematologic Disorders.
Immunol Allergy Clin North Am. 2015 Aug;35(3):439-52. doi: 10.1016/j.iac.2015.04.004.
8
Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.
Cancer Genet. 2017 Apr;212-213:38-44. doi: 10.1016/j.cancergen.2017.03.004. Epub 2017 Mar 27.
9
Imatinib Treatment of Lymphomatoid Papulosis Associated with Myeloproliferative Hypereosinophilic Syndrome Presenting the FIP1L1-PDGFRA Fusion Gene.
Acta Derm Venereol. 2017 Jul 6;97(7):855-857. doi: 10.2340/00015555-2669.
10
Molecular diagnosis and targeted therapy of a pediatric chronic eosinophilic leukemia patient carrying TPM3-PDGFRB fusion.
Pediatr Blood Cancer. 2011 Mar;56(3):463-6. doi: 10.1002/pbc.22800.
引用本文的文献
1
Clinical and Therapeutic Intervention of Hypereosinophilia in the Era of Molecular Diagnosis.
Cancers (Basel). 2024 Mar 31;16(7):1383. doi: 10.3390/cancers16071383.
2
Molecular mechanisms underlying nuchal hump formation in dolphin cichlid, Cyrtocara moorii.
Sci Rep. 2019 Dec 30;9(1):20296. doi: 10.1038/s41598-019-56771-7.
Zotero 插件